Shane William Charles Kovacs - 13 Jan 2026 Form 4 Insider Report for Olema Pharmaceuticals, Inc. (OLMA)

Role
CH. OPERATING & FINANCIAL OFF.
Signature
/s/ Shane Kovacs
Issuer symbol
OLMA
Transactions as of
13 Jan 2026
Net transactions value
-$2,980,054
Form type
4
Filing time
15 Jan 2026, 21:00:06 UTC
Previous filing
09 Dec 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Kovacs Shane William Charles CH. OPERATING & FINANCIAL OFF. C/O OLEMA PHARMACEUTICALS, INC., 780 BRANNAN ST, SAN FRANCISCO /s/ Shane Kovacs 15 Jan 2026 0001579397

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLMA Common Stock Sale $107,054 -3,822 -1.6% $28.01 239,727 13 Jan 2026 Direct F1
transaction OLMA Common Stock Sale $2,873,000 -100,000 -42% $28.73 139,727 15 Jan 2026 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The weighted average sale price for the transaction reported was $28.01, and the range of prices were between $28.00 and $28.03. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price will be provided.
F2 The weighted average purchase price for the transaction reported was $28.73, and the range of prices were between $28.50 and $29.18. Upon request from the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares purchased at each separate price will be provided.